CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 43 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $25,000 | 0.0% | 1,370 | 0.0% | 0.00% | – |
| Q3 2020 | $25,000 | -10.7% | 1,370 | -27.0% | 0.00% | – |
| Q2 2020 | $28,000 | -6.7% | 1,876 | -3.5% | 0.00% | – |
| Q1 2020 | $30,000 | -30.2% | 1,944 | -26.1% | 0.00% | – |
| Q4 2019 | $43,000 | +26.5% | 2,629 | +15.4% | 0.00% | – |
| Q3 2019 | $34,000 | 0.0% | 2,278 | 0.0% | 0.00% | – |
| Q2 2019 | $34,000 | +13.3% | 2,278 | +31.8% | 0.00% | – |
| Q1 2019 | $30,000 | -3.2% | 1,728 | 0.0% | 0.00% | – |
| Q4 2018 | $31,000 | 0.0% | 1,728 | 0.0% | 0.00% | – |
| Q3 2018 | $31,000 | -8.8% | 1,728 | 0.0% | 0.00% | – |
| Q2 2018 | $34,000 | -8.1% | 1,728 | -43.8% | 0.00% | – |
| Q1 2017 | $37,000 | -31.5% | 3,076 | -24.5% | 0.00% | – |
| Q4 2016 | $54,000 | +74.2% | 4,076 | +85.9% | 0.00% | – |
| Q3 2016 | $31,000 | +24.0% | 2,192 | 0.0% | 0.00% | – |
| Q2 2016 | $25,000 | – | 2,192 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|